Department of Neurology, Henry Ford Hospital and Wayne State University School of Medicine, Detroit, Michigan USA.
Transl Neurodegener. 2012 Jan 13;1(1):4. doi: 10.1186/2047-9158-1-4.
Tissue concentrations of norepinephrine (NE) are markedly decreased in various regions of the Parkinson's disease (PD) brain. As in the substantia nigra pars compacta, neuronal dropout and Lewy bodies are prominent changes affecting the locus coeruleus, which is the source of ascending NErgic projections. Despite the major roles of NE throughout the brain, there has been only minimal exploration of pharmacological intervention with NErgic neurotransmission. Cognitive operations, "freezing" of gait, tremor, dyskinesia, REM sleep regulation, and other aspects of brain function are tied into signaling by NE, and there is also evidence that it may have a role in the neurodegenerative process itself. This article reviews the reported pharmacological experience in PD therapeutics.
帕金森病（PD）大脑的各个区域去甲肾上腺素（NE）的组织浓度明显降低。与黑质致密部一样，神经元丢失和路易体是影响蓝斑的突出变化，蓝斑是上行 NE 投射的来源。尽管 NE 在整个大脑中起着重要作用，但对 NE 神经传递的药物干预的探索还很有限。认知操作、步态冻结、震颤、运动障碍、REM 睡眠调节和大脑功能的其他方面都与 NE 的信号有关，也有证据表明它可能在神经退行性过程本身中发挥作用。本文综述了 PD 治疗中的报道的药理学经验。
